|Description||Central Nervous Sys. Disease research|
|Venture Round, 4/05 |
Pitango Venture Capital
Shrem, Fudim, Kelner Technologies
|Venture Round, 8/08 |
Johnson & Johnson Development
Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases. BrainsGateâ€™s platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow.